Editor's note: The below transcript has been lightly edited for clarity.Hello, I am David Hutton of Ophthalmology Times. Welcome to another episode of This Week in Ophthalmology, a program looking at some of the week’s top headlines and videos.Earlier this year, I attended the 18th Annual Controversies in Modern Eye Care meeting on May 4, 2024, in Los Angeles, California. … [Read more...] about This Week in Ophthalmology: Week of December 9, 2024
News
VIDEO: ANX007 may prevent vision loss, preserve photoreceptors in geographic atrophy
December 13, 2024 1 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Rahul N. Khurana, MD, of Northern California Retina Vitreous Associates discusses phase 2 results for ANX007 for the treatment of geographic atrophy. According to Khurana, in the phase 2 ARCHER clinical trial, ANX007 (Annexon Biosciences) … [Read more...] about VIDEO: ANX007 may prevent vision loss, preserve photoreceptors in geographic atrophy
Tenpoint Therapeutics, Visus Therapeutics announce merger
December 13, 2024 1 min read Key takeaways: The merged company plans to file a new drug application for its presbyopia-correcting eye drop in 2025. Henric Bjarke has been appointed as CEO. Tenpoint Therapeutics and Visus Therapeutics announced the completion of their merger, according to a press release. The merger will support the development of the … [Read more...] about Tenpoint Therapeutics, Visus Therapeutics announce merger
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
The 14th annual Glaucoma 360 conference will take place February 6 to 8, 2025, at the Westin St. Francis on Union Square in San Francisco, California. Co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, the three-day event highlights progress in glaucoma care while fostering innovation and collaboration.The conference opens on … [Read more...] about California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education in San Francisco
The 14th annual Glaucoma 360 conference will take place February 6 to 8, 2025, at the Westin St. Francis on Union Square in San Francisco, California. Co-founded by Adrienne Graves, PhD, and Andrew Iwach, MD, and hosted by Glaucoma Research Foundation, the three-day event highlights progress in glaucoma care while fostering innovation and collaboration.The conference opens on … [Read more...] about California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education in San Francisco
Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment
Iantrek, Inc. has released 1-year follow-up data from the first 100 eyes enrolled in the CREST Registry, a prospective, real-world observational study assessing the outcomes of bio-interventional procedures for patients with open-angle glaucoma (OAG).The study, titled "One-Year Safety and Effectiveness of Bio-Interventional Cyclodialysis and Scleral Reinforcement in Open-Angle … [Read more...] about Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment
Phenocell and Amarna Therapeutics awarded Eurostars grant for continued investigation of dry AMD gene therapy platform
Two European companies received the competitive Eurostars grant to support a gene therapy platform for patients with dry age-related macular degeneration (AMD). Phenocell SAS (Axol Bioscience), a stem cell-derived model and service provider based in France, and Amarna Therapeutics, a gene therapy biotechnology firm based in the Netherlands, announced the award for their joint … [Read more...] about Phenocell and Amarna Therapeutics awarded Eurostars grant for continued investigation of dry AMD gene therapy platform
VisiRose introduces therapy for infectious keratitis
December 13, 2024 1 min read VisiRose, a collaboration between Provectus Biopharmaceuticals and Bascom Palmer Eye Institute, is introducing a therapy for the treatment of infectious keratitis and other eye infections, according to a press release. Rose bengal photodynamic antimicrobial therapy (RB PDAT), a noninvasive investigational treatment, uses a formulation of … [Read more...] about VisiRose introduces therapy for infectious keratitis
Study: Elevated NLR and SII levels linked to higher risk of cystoid macular edema
The results of a recent study indicated that elevated neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) levels may be associated significantly with cystoid macular edema (CME). The elevated levels may indicate a higher incidence of CME in these patients,1 according to researchers from the Department of Ophthalmology, Shantou University Medical … [Read more...] about Study: Elevated NLR and SII levels linked to higher risk of cystoid macular edema
VIDEO: Triamcinolone acetonide has good real-world results in uveitic macular edema
December 12, 2024 2 min watch CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Glenn C. Yiu, MD, PhD, of University of California, Davis, discusses suprachoroidal triamcinolone acetonide for uveitic macular edema. Data from the IRIS Registry show that triamcinolone acetonide “performs very well in real-world settings” to treat … [Read more...] about VIDEO: Triamcinolone acetonide has good real-world results in uveitic macular edema